The 2022 MRA for Gene Therapy in Hemophilia A Program has launched. Full Proposals are due Friday, February 11, 2022.
This special HTRS Mentored Research Award (MRA) for Gene Therapy in Hemophilia A Program will provide a grant for a qualified fellow or junior attending/junior faculty (MDs, DOs, MBBSs or the equivalent) pursuing clinical, translational, or basic science research projects in Gene Therapy in Hemophilia A under the guidance of an experienced mentor.
The goals of the overall HTRS MRA Program are to:
2022 HTRS MRA for Gene Therapy in Hemophilia A: Request for Proposals (RFP)
Revised Budget Form for this MRA - Updated 12.15.2021
All applications are submitted on the HTRS grant application site at https://htrs.smapply.org Applicants who have not applied for an HTRS awards on Survey Monkey Apply previously should click on "Register" and create a new account with an email and password. The site allows you to save your work and return to it later.
Please contact HTRS at [email protected] if you have any questions.
Bhavya S. Doshi, MD
Julie A. Jaffray, MD
Allyson M. Pishko, MD, MSCE
Alec A. Schmaier, MD, PhD
Silver Level Supporters:
Shruti Chaturvedi, MBBS, MCSI
Ang Li, MD
Ming Y. Lim, MB BChir, MA
Deepti M. Warad, MBBS
Patricia E. Zerra, MD
.
Gold Level Supporters:
Novo Nordisk is a Founding Supporter of the MRA Program
Silver Level Supporter:
Maissaa Janbain, MD
Oluwatoyosi (Toyosi) A. Onwuemene, MD, MS
Sol Schulman, MD, PhD
Michelle Sholzberg, MDCM, MSc, FRCPC
Angela C. Weyand, MD
Bronze Level Supporters:
Glaivy M. Batsuli, MD
Joan D. Beckman, MD, PhD
Peter H. Cygan, MD
Lindsey A. George, MD
Riten Kumar, MD, MSc
Arash Mahajerin, MD, MSCr
Bioverativ Therapeutics
CSL Behring
Novo Nordisk Inc.
Takeda
Pavan K. Bendapudi, MD
Rachel S. Bercovitz, MD
Grace M. Lee, MD
Benjamin J. Samelson-Jones, MD
Anish V. Sharda, MBBS, MPH
Supported by educational grants from: Novo Nordisk Inc.